Thoracic Aortic Aneurysm. Clinically Pertinent Controversies and Uncertainties

Journal of the American College of Cardiology

Volumn 55, Issue 9, 2010, Pages 841-857

  Elefteriades, John A ^a   Farkas, Emily A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aneurysm; aortic; diagnosis; genetics; thoracic

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; D DIMER; DOXYCYCLINE; ELASTIN; ENDOTHELIN; FIBRILLIN 1; FIBRINOGEN; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; MATRIX METALLOPROTEINASE; PLASMIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RAPAMYCIN; RNA; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; ANEURYSM SURGERY; AORTA DISSECTION; AORTA RUPTURE; AORTA WALL; ARTERIOSCLEROSIS; ARTERY DIAMETER; CARDIAC PATIENT; CARDIOVASCULAR RISK; CAUSE OF DEATH; CD4 CD8 RATIO; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; ECHOCARDIOGRAPHY; ELASTICITY; ENDOVASCULAR SURGERY; EVIDENCE BASED MEDICINE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HERITABILITY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; MARFAN SYNDROME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STENT; THORACIC AORTA; THORACIC AORTA ANEURYSM; TREATMENT OUTCOME;

AORTIC ANEURYSM, THORACIC; AORTOGRAPHY; ECHOCARDIOGRAPHY; HUMANS; INCIDENCE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 76849110255     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.08.084     Document Type: Review

References (59)

1. Napoli A., Anzidei M., Francone M., et al. 64-MDCT imaging of the coronary arteries and systemic arterial vascular tree in a single examination: optimisation of the scan protocol and contrast-agent administration. Radiol Med 113 (2008) 799-816
2. Muhs B.E., Vincken K.L., van Prehn J., et al. Dynamic cine-CT angiography for the evaluation of the thoracic aorta; insight in dynamic changes with implications for thoracic endograft treatment. Eur J Vasc Endovasc Surg 32 (2006) 532-536
3. Schlösser F.J., Mojibian H.R., Dardik A., Verhagen H.J., Moll F.L., and Muhs B.E. Simultaneous sizing and preoperative risk stratification for thoracic endovascular aneurysm repair: role of gated computed tomography. J Vasc Surg 48 (2008) 561-570
4. Coady M.A., Rizzo J.A., Hammond G.L., Kopf G.S., and Elefteriades J.A. Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications. Ann Thorac Surg 67 (1999) 1922-1926
5. Elefteriades J.A., Rizzo J.A., and Coady M.A. Thoracic aorta. Radiology 211 (1999) 889
6. Elefteriades J.A., and Rizzo J.A. Epidemiology, prevalence, incidence, trends. In: Elefteriades J.A. (Ed). Acute Aortic Disease (2008), Informa Healthcare, New York, NY 89-98
7. Elefteriades J.A., Barrett P.W., and Kopf G.S. Litigation in non-traumatic diseases?. A tempest in the malpractice maelstrom. Cardiology 109 (2007) 263-272
8. National Center for Health Statistics. National Vital Statistics System. http://www.cdc.gov/nchs/nvss.htm Accessed April 10, 2009
9. National Center for Injury Prevention and Control. WISQARS Leading Causes of Death Reports, 1999-2006. http://webappa.cdc.gov/sasweb/ncipc/leadcaus10.html Accessed April 10, 2009
10. Anagnostopoulos C.E. Diagnosis of aortic dissection. In: Anagnostopoulos C.E. (Ed). Acute Aortic Dissections (1975), University Park Press, Baltimore, MD 124-127
11. Clouse W.D., Hallett Jr. J.W., Schaff H.V., et al. Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc 79 (2004) 176-180
12. Acosta S., Ogren M., Bengtsson H., Bergqvist D., Lindblad B., and Zdanowski Z. Increasing incidence of ruptured abdominal aortic aneurysm: a population-based study. J Vasc Surg 44 (2006) 237-243
13. Rizzo J.A., Coady M.A., and Elefteriades J.A. Procedures for estimating growth rates in thoracic aortic aneurysms. J Clin Epidemiol 51 (1998) 747-754
14. Koullias G.J., Ravichandran P., Korkolis D.P., Rimm D.L., and Elefteriades J.A. Increased tissue microarray MMP expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 78 (2004) 2106-2110
15. Pape L.A., Tsai T.T., Isselbacher E.M., Oh J.K., et al. Aortic diameter >5.5 cm is not a good predictor of type A aortic dissection-observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation 116 (2007) 1120-1127
16. Koullias G., Modak R., Tranquilli M., Korkolis D.P., Barash P., and Elefteriades J.A. Mechanical deterioration underlies malignant behavior of aneurysmal human ascending aorta. J Thorac Cardiovasc Surg 130 (2005) 677-683
17. Leung J.H., Wright A.R., Cheshire N., et al. Fluid structure interaction of patient specific abdominal aortic aneurysms: a comparison with solid stress models. Biomed Eng Online 19 (2006) 33
18. Poullis M.P., Warwick R., Oo A., and Poole R.J. Ascending aortic curvature as an independent risk factor for type A dissection, and ascending aortic aneurysm formation: a mathematical model. Eur J Cardiothorac Surg 33 (2008) 995-1001
19. Truijers M., Kurvers H.A., Bredie S.J., Oven W.J., and Blankensteijn J.D. In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall. Endovasc Ther 15 (2008) 462-467
20. Reeps C., Essler M., Pelisek J., Seidl S., Eckstein H.H., and Krause B.J. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg 48 (2008) 417-423
21. Shores J., Berger K.R., Murphy E.A., and Pyeritz R.E. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 330 (1994) 1335-1341
22. Feldman M., Shah M., and Elefteriades J.A. Medical management of acute type A aortic dissection. Ann Cardiovasc Thorac Surg 15 (2009) 286-293
23. Hackmann A.E., Thompson R.W., and LeMaire S.A. Long term suppressive therapy: clinical reality and future prospects. In: Elefteriades J.A. (Ed). Acute Aortic Disease (2007), Informa Healthcare, New York, NY 309-330
24. Lindholt J.S., Henneberg E.W., Juul S., and Fasting H. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. Int J Angiol 18 (1999) 52-57
25. Habashi J.P., Judge D.P., Holm T.M., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006) 117-121
26. Lacro R.V., Dietz H.C., Wruck L.M., et al., Pediatric Heart Network Investigators. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J 154 (2007) 624-631
27. Brooke B.S., Habashi J.P., Judge D.P., Patel N., Loeys B., and Dietz III H.C. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 358 (2008) 2787-2795
28. Mosorin M., Juvonen J., Biancari F., et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 34 (2001) 606-610
29. Abdul-Hussien H., Hanemaaijer R., Verheijen J.H., van Bockel J.H., Geelkerken R.H., and Lindeman J.H. Doxycycline therapy for abdominal aneurysm: improved proteolytic balance through reduced neutrophil content. J Vasc Surg 49 (2009) 741-749
30. Dawson J., Choke E., Sayed S., Cockerill G., Loftus I., and Thompson M.M. Pharmacotherapy of abdominal aortic aneurysms. Curr Vasc Pharmacol 4 (2006) 129-149
31. Guessous I., Periard D., Lorenzetti D., Cornuz J., and Ghali W.A. The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta-analysis. PLoS One 3 (2008) e1895
32. Elefteriades J.A. Beating a sudden killer. Sci Am 293 (2005) 64-71
33. Elefteriades J.A., Hatzaras I., Tranquilli M.A., et al. Weight lifting and rupture of silent aortic aneurysms. JAMA 290 (2003) 2803
34. Hatzaras I., Tranquilli M., Coady M.A., Barrett P.W., Bible J., and Elefteriades J.A. Weight lifting and aortic dissection: more evidence for a connection. Cardiol 107 (2006) 103-106
35. Coady M.A., Davies R.R., Roberts M., et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 134 (1999) 361-367
36. Albornoz G., Coady M.A., Roberts M., Davies R.R., Rizzo J., and Elefteriades J.A. Familial thoracic aortic aneurysms and dissections-incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg 82 (2006) 1400-1405
37. Milewicz D.M., Michael K., Fisher N., Coselli J.S., Markello T., and Biddinger A. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation 94 (1996) 2708-2711
38. Putnam E.A., Zhang H., Ramirez F., and Milewicz D.M. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet 11 (1995) 456-458
39. Hasham S.N., Lewin M.R., Tran V.T., et al. Nonsyndromic genetic predisposition to aortic dissection: a newly recognized, diagnosable, and preventable occurrence in families. Ann Emerg Med 43 (2004) 79-82
40. Hasham S.N., Willing M.C., Guo D.C., et al. Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation 107 (2003) 3184-3190
41. Wang Y., Barbacioru C.C., Shiffman D., et al. Gene expression signature in peripheral blood detects thoracic aortic aneurysm. PLoS One 2 (2007) e1050
42. Elefteriades J.A., Trimarchi S., and Sangiorgi G. Blood test for aneurysm. In: Kimchi A. (Ed). Current Advances in Heart Disease. Proceedings of the 13th World Congress on Heart Disease. Toronto, ON, Canada, July 26-29, 2008 (2009), Medimond, Bologna, Italy 311-326
43. Ohlmann P., Faure A., Morel O., et al. Diagnostic and prognostic value of circulating D-dimers in patients with acute aortic dissection. Crit Care Med 34 (2006) 1358-1364
44. Lorelli D.R., Jean-Claude J.M., Fox C.J., et al. Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak. J Vasc Surg 35 (2002) 916-922
45. Monaco M., Stassano P., Di Tommaso L., and Iannelli G. Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms. J Thorac Cardiovasc Surg 134 (2007) 925-931
46. Davies R.R., Goldstein L.J., Coady M.A., et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 73 (2002) 17-28
47. Elefteriades J.A., and Percy A. Endovascular stenting for descending aneurysms: wave of the future or the emperor's new clothes?. J Thorac Cardiovasc Surg 133 (2007) 285-288
48. Blankensteijn J. Late results of endovascular aneurysm repair versus open aneurysm repair. Paper presented at: International Meeting on Aortic Aneurysms: New Insights Into an Old Problem. Palais des Congres, Liege, Belgium (September 19-20, 2008)
49. EVAR Trial Participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 365 (2005) 2187-2192
50. Blankensteijn J. Late results of endovascular aneurysm repair versus open aneurysm repair. International Meeting on Aortic Aneurysms: new insights into an old problem. Paper presented at: Palais des Congres. Liege, Belgium (September 19-20, 2008)
51. Aliabri B., Al Wahaibi K., Abner D., et al. Patient-reported quality of life after abdominal aortic aneurysm surgery: a prospective comparison of endovascular and open repair. J Vasc Surg 44 (2006) 1182-1187
52. Kalef-Ezra J.A., Karavasilis S., Ziogas D., Dristilliaris D., Michalis L., and Matsagas M. Radiation burden of patients undergoing endovascular abdominal aortic aneurysm repair. J Vasc Surg 49 (2009) 283-287 discussion 287
53. Achneck H.E., Rizzo J.A., Tranquilli M., and Elefteriades J.A. Safety of thoracic surgery in the present era. Ann Thorac Surg 84 (2007) 1180-1185
54. Clagett G.P. EVAR, TEVAR, FEVAR, too far?. Perspect Vasc Surg Endovasc Ther 20 (2008) 115-119
55. Hatzaras I.S., Bible J.E., Kallias G.J., et al. Role of exertion or emotion as inciting events for acute aortic dissection. Am J Cardiol 100 (2007) 1470-1472
56. Achneck H., Modi B., Shaw C., et al. Ascending thoracic aneurysms are associated with decreased systemic atherosclerosis. Chest 128 (2005) 1580-1586
57. Bendeck M.P. Matrix metalloproteinases: are they antiatherogenic but proaneurysmal?. Circ Res 90 (2002) 836-837
58. Silence J., Collen D., and Lijnen H.R. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res 90 (2002) 897-903
59. Osler W. Notes on aneurism. JAMA 38 (1902) 1483-1486